• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ROE(放射治疗结果估算器):一种用于优化放射治疗方案的开源工具。

ROE (Radiotherapy Outcomes Estimator): An open-source tool for optimizing radiotherapy prescriptions.

机构信息

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, United States.

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, United States.

出版信息

Comput Methods Programs Biomed. 2023 Dec;242:107833. doi: 10.1016/j.cmpb.2023.107833. Epub 2023 Oct 14.

DOI:10.1016/j.cmpb.2023.107833
PMID:37863013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10872836/
Abstract

BACKGROUND AND OBJECTIVES

Radiotherapy prescriptions currently derive from population-wide guidelines established through large clinical trials. We provide an open-source software tool for patient-specific prescription determination using personalized dose-response curves.

METHODS

We developed ROE, a plugin to the Computational Environment for Radiotherapy Research to visualize predicted tumor control and normal tissue complication simultaneously, as a function of prescription dose. ROE can be used natively with MATLAB and is additionally made accessible in GNU Octave and Python, eliminating the need for commercial licenses. It provides a curated library of published and validated predictive models and incorporates clinical restrictions on normal tissue outcomes. ROE additionally provides batch-mode tools to evaluate and select among different fractionation schemes and analyze radiotherapy outcomes across patient cohorts.

CONCLUSION

ROE is an open-source, GPL-copyrighted tool for interactive exploration of the dose-response relationship to aid in radiotherapy planning. We demonstrate its potential clinical relevance in (1) improving patient awareness by quantifying the risks and benefits of a given treatment protocol (2) assessing the potential for dose escalation across patient cohorts and (3) estimating accrual rates of new protocols.

摘要

背景与目的

目前,放疗方案源自通过大型临床试验制定的全人群指南。我们提供了一个开源软件工具,用于使用个性化剂量-反应曲线来确定患者特异性处方。

方法

我们开发了 ROE,这是一个 Computational Environment for Radiotherapy Research 的插件,可用于可视化预测的肿瘤控制和正常组织并发症同时作为处方剂量的函数。ROE 可以在 MATLAB 中本地使用,并且还可以在 GNU Octave 和 Python 中使用,从而消除了对商业许可证的需求。它提供了一个经过精心策划的已发表和经过验证的预测模型库,并纳入了对正常组织结果的临床限制。ROE 还提供了批处理模式工具,用于评估和选择不同的分割方案,并分析患者队列中的放疗结果。

结论

ROE 是一个开源的、遵循 GPL 版权协议的工具,用于交互式探索剂量-反应关系,以辅助放疗计划。我们通过以下方面证明了其潜在的临床相关性:(1)通过量化给定治疗方案的风险和益处来提高患者的意识;(2)评估患者队列之间的剂量递增潜力;(3)估计新方案的累积率。

相似文献

1
ROE (Radiotherapy Outcomes Estimator): An open-source tool for optimizing radiotherapy prescriptions.ROE(放射治疗结果估算器):一种用于优化放射治疗方案的开源工具。
Comput Methods Programs Biomed. 2023 Dec;242:107833. doi: 10.1016/j.cmpb.2023.107833. Epub 2023 Oct 14.
2
Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships.剂量反应浏览器:一种用于探索和建模放射治疗剂量-体积结果关系的集成开源工具。
Phys Med Biol. 2006 Nov 21;51(22):5719-35. doi: 10.1088/0031-9155/51/22/001. Epub 2006 Oct 19.
3
Dose-response modeling and treatment plan assessment with a python software toolkit.剂量反应建模和治疗计划评估的 Python 软件工具包。
Med Dosim. 2024;49(4):340-352. doi: 10.1016/j.meddos.2024.04.005. Epub 2024 May 22.
4
Towards biologically conformal radiation therapy (BCRT): selective IMRT dose escalation under the guidance of spatial biology distribution.迈向生物适形放射治疗(BCRT):在空间生物学分布指导下的选择性调强放射治疗剂量递增
Med Phys. 2005 Jun;32(6):1473-84. doi: 10.1118/1.1924312.
5
Towards optimal heterogeneous prostate radiotherapy dose prescriptions based on patient-specific or population-based biological features.基于患者特异性或群体特异性生物学特征的最优异质前列腺放射治疗剂量处方。
Med Phys. 2024 May;51(5):3766-3781. doi: 10.1002/mp.16936. Epub 2024 Jan 15.
6
Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite.使用 BioSuite 进行放射治疗中处方剂量和分割方案的放射生物学引导优化。
Br J Radiol. 2012 Sep;85(1017):1279-86. doi: 10.1259/bjr/20476567. Epub 2012 Mar 28.
7
MMCTP: a radiotherapy research environment for Monte Carlo and patient-specific treatment planning.MMCTP:用于蒙特卡洛和针对患者的治疗计划的放射治疗研究环境。
Phys Med Biol. 2007 Jul 7;52(13):N297-308. doi: 10.1088/0031-9155/52/13/N03. Epub 2007 Jun 6.
8
EUCLID: an outcome analysis tool for high-dimensional clinical studies.EUCLID:一种用于高维临床研究的结果分析工具。
Phys Med Biol. 2007 Mar 21;52(6):1705-19. doi: 10.1088/0031-9155/52/6/011. Epub 2007 Feb 27.
9
Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy.自动化治疗计划在胰腺立体定向体放射治疗剂量递增中的技术评估。
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819851520. doi: 10.1177/1533033819851520.
10
Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription.通过个体化等毒剂量处方提高立体定向消融放疗的治疗比。
J Natl Cancer Inst. 2015 Oct 16;108(2). doi: 10.1093/jnci/djv305. Print 2016 Feb.

引用本文的文献

1
Data Science Opportunities To Improve Radiotherapy Planning and Clinical Decision Making.数据科学在改善放射治疗计划和临床决策方面的机遇。
Semin Radiat Oncol. 2024 Oct;34(4):379-394. doi: 10.1016/j.semradonc.2024.07.012.

本文引用的文献

1
Simulating the Potential of Model-Based Individualized Prescriptions for Ultracentral Lung Tumors.模拟基于模型的超中心型肺肿瘤个体化处方的潜力。
Adv Radiat Oncol. 2023 Jun 5;8(6):101285. doi: 10.1016/j.adro.2023.101285. eCollection 2023 Nov-Dec.
2
External validation of pulmonary radiotherapy toxicity models for ultracentral lung tumors.超中心型肺肿瘤肺部放射治疗毒性模型的外部验证
Clin Transl Radiat Oncol. 2022 Nov 4;38:57-61. doi: 10.1016/j.ctro.2022.10.012. eCollection 2023 Jan.
3
Treatment planning and outcomes effects of reducing the preferred mean esophagus dose for conventionally fractionated non-small cell lung cancer radiotherapy.
常规分割非小细胞肺癌放疗降低食管平均适形剂量的治疗计划和结果影响。
J Appl Clin Med Phys. 2021 Feb;22(2):42-48. doi: 10.1002/acm2.13150. Epub 2021 Jan 25.
4
Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617.在NRG肿瘤学试验RTOG 0617中模拟心肺照射对总生存期的影响
Clin Cancer Res. 2020 Sep 1;26(17):4643-4650. doi: 10.1158/1078-0432.CCR-19-2627. Epub 2020 May 12.
5
Integrating Mathematical Modeling into the Roadmap for Personalized Adaptive Radiation Therapy.将数学建模融入个性化自适应放射治疗路线图
Trends Cancer. 2019 Aug;5(8):467-474. doi: 10.1016/j.trecan.2019.06.006. Epub 2019 Jul 10.
6
Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models.局部晚期非小细胞肺癌的个体化剂量处方:已发表的正常组织并发症概率模型的验证。
Radiother Oncol. 2019 Sep;138:45-51. doi: 10.1016/j.radonc.2019.05.011. Epub 2019 May 27.
7
Automated intensity modulated treatment planning: The expedited constrained hierarchical optimization (ECHO) system.自动化强度调制治疗计划:加速约束分层优化(ECHO)系统。
Med Phys. 2019 Jul;46(7):2944-2954. doi: 10.1002/mp.13572. Epub 2019 May 29.
8
Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors.中央型肺部肿瘤立体定向和适形分割放射治疗后肺毒性的正常组织并发症概率模型。
Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):738-747. doi: 10.1016/j.ijrobp.2017.11.022. Epub 2017 Nov 21.
9
Modeling the Cellular Response of Lung Cancer to Radiation Therapy for a Broad Range of Fractionation Schedules.为广泛的分割方案模拟肺癌对放射治疗的细胞反应。
Clin Cancer Res. 2017 Sep 15;23(18):5469-5479. doi: 10.1158/1078-0432.CCR-16-3277. Epub 2017 May 24.
10
A validated tumor control probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy.基于对接受光子、质子或碳离子放疗的低、中、高危前列腺癌患者进行的荟萃分析建立的经过验证的肿瘤控制概率模型。
Med Phys. 2016 Feb;43(2):734-47. doi: 10.1118/1.4939260.